How effective will Bharat Biotech’s new cholera vaccine be?


Cholera vaccine : Bharat Biotech is manufacturing an oral vaccine to rid the world of cholera. After getting approval from DCGI, Bharat Biotech International Limited has started working on it. The name of this oral vaccine is Hillchol. According to reports, around 3,600 Indian participants have taken part in the third phase clinical trial. It has been found that this vaccine is completely safe and its effect is not less than the existing vaccine.

Let us tell you that the demand for Oral Cholera Vaccine (OCV) worldwide is over 10 million doses. Only 6 crore doses of OCV are available worldwide. The new vaccine can play an important role in filling the gap of four crore doses.

Where is the oral cholera vaccine manufactured?

How will the vaccine work?

How many cases of cholera in the world?

Globally, cholera deaths have been on the rise since 2021. However, its treatment is possible. Between the beginning of 2023 and March this year, 824,479 cases of cholera were reported in 31 countries, of which 5,900 died. According to reports, these doses will benefit not only India but also the African continent, where the cholera situation is getting worse. African countries will have to buy this vaccine from India.

Disclaimer: Some information given in the news is based on media reports. Before implementing any suggestion, you must consult the concerned expert.

Also read:

Anemia in Women: 40% of women in India suffer from anemia, you know what

Discover the health tools below-
Calculate your body mass index (BMI)

  Covid-induced mental illnesses spike gender violence in urban areas: Study

Calculate age by age calculator



Source link

Leave a Comment